Skip to main content
Signal8

Field Katharyn

SEC insider (Form 3/4/5 filer). CIK 0002029888. Chief Financial Officer at Advasa Holdings, Inc. (ADBT) and 4 other issuers. 1 reported Form 4/5 transaction since Sep 2024; latest on Sep 25, 2024. Located in WOBURN, MA.

Companies Field Katharyn has filed insider reports for

  • Advasa Holdings, Inc. (ADBT): Officer, Chief Financial Officer
  • BioRestorative Therapies, Inc. (BRTX): Director
  • LOGPROSTYLE INC. (LGPS): Director, Officer, Director and Executive Officer
  • Nuwellis, Inc. (NUWE): Director
  • iSpecimen Inc. (ISPC): Director
Field Katharyn profile photo

Field Katharyn

CIK: 0002029888

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (5)

Advasa Holdings, Inc. logo
ADBT

Advasa Holdings, Inc.

Officer
BioRestorative Therapies, Inc. logo
BRTX

BioRestorative Therapies, Inc.

Director
LOGPROSTYLE INC. logo
LGPS

LOGPROSTYLE INC.

DirectorOfficer
Nuwellis, Inc. logo
NUWE

Nuwellis, Inc.

Director
iSpecimen Inc. logo
ISPC

iSpecimen Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • iSpecimen Inc. logo
    ISPC

    iSpecimen Inc.

    Sep 25, 2024
    Award

    Option

    Direct
    168 shares at avg. $5.12-

1-1 of 1